Form 8-K - Current report:
SEC Accession No. 0001140361-23-057644
Filing Date
2023-12-14
Accepted
2023-12-14 16:10:28
Documents
14
Period of Report
2023-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20016672_8k.htm   iXBRL 8-K 29944
2 EXHIBIT 99.1 ef20016672_ex99-1.htm EX-99.1 10199
6 image0.jpg GRAPHIC 11357
  Complete submission text file 0001140361-23-057644.txt   195298

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20231214.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20231214_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20231214_pre.xml EX-101.PRE 16050
8 EXTRACTED XBRL INSTANCE DOCUMENT ef20016672_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 231487189
SIC: 2834 Pharmaceutical Preparations